ValiRx Share News (VAL)
VAL Share
VAL Share
VAL Share
VAL Share
VAL
VAL Share
VAL Level 2
VAL Live
VAL Broker
VAL Directors
VAL Financial
VAL
VAL Short
VAL
Last checked at -
Tue, 24th Sep 2019 12:40
(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said on Tuesday it has received an HMRC research & development tax credit of GBP423,000.
The company said it continues to "carefully manage" its working capital position.
Shares in ValiRx were up 7.6% at 0.1667 pence in London on Tuesday.
By Lucy Heming; lucyheming@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/
Read more(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,
Read more
Last checked at